HEC53856 clinical trials
Also written HEC53856.
How each study uses HEC53856 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the HEC53856 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- HEC53856
- 3
Studies by the year they started
4 studies that test it; most in 2021 (2)
| Year | Studies |
|---|---|
| 2019 | 1 |
| 2021 | 2 |
| 2026 | 1 |
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses HEC53856 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- HEC53856 Tablets for Chemotherapy-induced Anemia in Non-myeloid MalignanciesNot yet recruitingPhase 2Sunshine Lake Pharma Co., Ltd.NCT07891377Written as HEC53856 tablet
- Study of HEC53856 in Patients With Subjects With End-Stage Renal Disease Receiving Dialysis.CompletedPhase 1Sunshine Lake Pharma Co., Ltd.NCT04925674Written as HEC53856
- HEC53856 Phase Ib Study in Patients With Non-dialysis Renal AnemiaCompletedPhase 1Sunshine Lake Pharma Co., Ltd.NCT04925661Written as HEC53856
- HEC53856 Phase 1 Study - Single and Multiple Oral Dosing in Healthy VolunteersCompletedPhase 1Sunshine Lake Pharma Co., Ltd.NCT03886688Written as HEC53856
What changed recently
From the registry's own updates since Oct 18, 2026.
Newly registered1
- HEC53856 Tablets for Chemotherapy-induced Anemia in Non-myeloid MalignanciesOct 23, 2026NCT07891377